The company already has sales of its 3D Stereoscopic Vision System endoscope in the US and Europe.
3D minimally invasive surgical solutions developer VisionSense Ltd. has raised $8 million from Volcano Capital Ltd., Wheatley Capital, TechnoPlus Ventures Ltd. (TASE:TNPV), and other investors.
Founded as EnVision in 1998, VisionSense is now at the market penetration stage for its product, Visionsense Stereoscopic Vision System endoscope, which provides a 3D image for diagnosis or navigation for minimally invasive surgical procedures.
VisionSense already has sales in the US and Europe, and is planning an organized penetration of the market, either via its own marketing staff, or through distributors. The proceeds from the round are slated for this purpose, as well as for the development of new products.
Lewis Pell invested in VisionSense in 2004. Pell and Prof. Shlomo Ben-Haim have invested in dozens of start-ups and made more than $500 million in exits, including in Biosense, Instent, Disc-o-Tech Ltd., and X-Technologies.
Other shareholders in VisionSense include GlenRock Israel, Star Ventures, abd Shalom Equity Fund.